17 alpha-hydroxyprogesterone caproate has been researched along with Infantile Respiratory Distress Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aboulghar, MA; Aboulghar, MM; Amin, YM; Awwad, J; Briery, CM; Cam, C; Caritis, SN; Çetingöz, E; Combs, CA; Fonseca, EB; Garite, T; Groenwold, RH; Karateke, A; Kwee, A; Lim, AC; Magann, EF; Maurel, K; Meseguer, J; Mol, BW; Moons, KG; Morrison, JC; Nassar, AH; Nicolaides, KH; Norman, JE; Perales, A; Rode, L; Ross, S; Rouse, DJ; Schuit, E; Serra, V; Stock, S; Tabor, A; Thom, EA; Usta, IM; Vayssiere, C; Wood, S; Worda, K; Zuithoff, NP | 1 |
| Awwad, J; Ghazeeri, G; Hayek, S; Nassar, AH; Saasouh, W; Succar, J; Usta, IM; Yacoub, N | 1 |
| Abril, D; Clewell, W; Combs, CA; Das, A; Garite, TJ; Heyborne, K; How, H; Huang, W; Lewis, D; Lu, G; Maurel, K; Miller, H; Nageotte, M; Porreco, R; Sheikh, A; Tran, L | 1 |
1 review(s) available for 17 alpha-hydroxyprogesterone caproate and Infantile Respiratory Distress Syndrome
| Article | Year |
|---|---|
Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Administration, Intravaginal; Adult; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Cervical Length Measurement; Cervix Uteri; Enterocolitis, Necrotizing; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Infant, Newborn, Diseases; Perinatal Death; Pregnancy; Pregnancy, Twin; Premature Birth; Progesterone; Progestins; Respiratory Distress Syndrome, Newborn; Treatment Outcome | 2015 |
2 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Infantile Respiratory Distress Syndrome
| Article | Year |
|---|---|
A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Double-Blind Method; Female; Gestational Age; Humans; Hydroxyprogesterones; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Injections, Intramuscular; Odds Ratio; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Pregnancy, Twin; Premature Birth; Progestins; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity; Sepsis | 2015 |
17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Cerebral Hemorrhage; Double-Blind Method; Early Termination of Clinical Trials; Enterocolitis, Necrotizing; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Hydroxyprogesterones; Infant, Newborn; Infant, Premature; Injections, Intramuscular; Leukomalacia, Periventricular; Perinatal Mortality; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Progestins; Proportional Hazards Models; Respiratory Distress Syndrome, Newborn; Sepsis; Time Factors; Treatment Outcome; Watchful Waiting; Young Adult | 2015 |